SMAD4 and KRAS status shape malignant-stromal crosstalk in pancreatic cancer
Eloise G. Lloyd, Muntadher Jihad, Judhell S. Manansala, Wenlong Li, Priscilla S.W. Cheng, Sara Pinto Teles, Gianluca Mucciolo, Joaquín Araos Henríquez, Sally Ashworth, Weike Luo, Sneha Harish, Paul M. Johnson, Lisa Veghini, Marta Zaccaria, Rebecca J. Brais, , Giulia Biffi
This study shows that SMAD4 and KRAS mutations influence stromal composition and therapeutic response in pancreatic cancer models.
Cancer Research · Jan 21, 2025Peer-reviewedCancer Biology